Systematic Review
Published on 26 Sep 2022
Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis from randomized controlled trials
in Neuroepidemiology
- 2,979 views
- 1 citation